Core Insights - The article highlights the misuse of prescription drugs like Semaglutide and Tirzepatide, which are being marketed as "miracle weight loss drugs" on social media platforms, despite their intended use for specific medical conditions like type 2 diabetes [1][2][3] - There is a concerning trend where prescriptions can be easily altered to meet the demands of buyers, undermining the strict regulations that should govern the use of these medications [1][2] Group 1: Prescription Drug Misuse - The misuse of prescription drugs for weight loss is not a new phenomenon, but recent investigations reveal that prescriptions can be modified based on buyer requests, compromising the integrity of medical guidelines [1] - Semaglutide is approved in China for diabetes management and has a specific version for weight loss, which is only suitable for certain obese populations, requiring thorough diagnostic evaluations before prescription [2] Group 2: Regulatory Gaps - Current prescription management has multiple loopholes, such as the lack of anti-counterfeiting measures for external prescriptions and inadequate verification processes at pharmacies, which facilitate the misuse of these drugs [2] - Establishing a comprehensive electronic prescription system is essential for tracking the entire process of prescription issuance, review, and circulation to prevent misuse [2] Group 3: Public Awareness and Attitude - The article emphasizes the importance of fostering a healthy societal attitude towards weight loss, as misleading advertisements on social media promote unrealistic weight loss expectations and the use of unverified drugs [3] - It is crucial for the public to adopt a scientific approach to weight loss, recognizing that medications should only be used as adjuncts to diet and exercise under professional guidance [3]